← Eichor
Study identifier: NCT07040592 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

Condition: Alcohol Use Disorder (AUD) · HIV  ·  Sponsor: Yale University

PhasePhase 2
Planned participants30
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reducing alcohol use among individuals with HIV and AUD.

This description comes directly from the study's public registry record.

Talk to the study team

E. Jennifer Edelman, MD, MHS  ·  203-737-7115  ·  ejennifer.edelman@yale.edu

June-Marie Weiss, MA, MEd  ·  203-737-3347  ·  junemarie.weiss@yale.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Atlanta VA Medical CenterDecatur, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07040592